Cargando…

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

SUMMARY: BACKGROUND: The optimal dose of grass pollen tablets for sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients was previously established in a multinational, randomized, double-blind, placebo-controlled study in 628 adults. Patients were randomized to receive once-daily 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malling, H-J, Montagut, A, Melac, M, Patriarca, G, Panzner, P, Seberova, E, Didier, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Original Articles: Editor's Choice: Clinical Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233960/ https://www.ncbi.nlm.nih.gov/pubmed/19134019 http://dx.doi.org/10.1111/j.1365-2222.2008.03152.x

Ejemplares similares

161 Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in us Adults With Grass-Pollen Allergic Rhinoconjunctivitis
por: Cox, Linda, et al.
Publicado: (2012)

5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis
por: Didier, Alain, et al.
Publicado: (2012)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
por: Horak, F, et al.
Publicado: (2009)

“The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”
por: Demoly, Pascal, et al.
Publicado: (2015)

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study
por: Schäfer, Udo, et al.
Publicado: (2017)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

488 The Effect of Specific Immunotherapy on the Clinical Response in Patients with Grass-pollen Induced Rhinoconjunctivitis
por: Arsovski, Zoran, et al.
Publicado: (2012)

PD14 - Non-interventional 2-year study of sublingual immunotherapy in children and adolescents with allergic rhinoconjunctivitis caused by grass pollen
por: Karagiannis, Efstrathios, et al.
Publicado: (2014)

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC)
por: Hebert, Jacques, et al.
Publicado: (2011)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
por: Worm, Margitta, et al.
Publicado: (2014)

Personalized Pollen Monitoring and Symptom Scores: A Feasibility Study in Grass Pollen Allergic Patients
por: de Weger, Letty A., et al.
Publicado: (2021)

157 The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults With Allergic Rhinitis
por: Bergmann, Karl-Christian, et al.
Publicado: (2012)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
por: Antolín-Amerigo, Darío, et al.
Publicado: (2017)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2023)

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis
por: Kim, Harold, et al.
Publicado: (2014)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
por: Ellis, Anne K., et al.
Publicado: (2021)

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
por: Rønborg, Steen M, et al.
Publicado: (2012)

Factors predicting the outcome of allergen-specific nasal provocation test in children with grass pollen allergic rhinitis
por: Barreto, M., et al.
Publicado: (2023)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
por: Proctor, Thomas, et al.
Publicado: (2020)

176 Sublingual Immunotherapy for Grass Pollen Allergy in Children: A Systematic Review and Meta-Analysis
por: Bryson, Rebecca
Publicado: (2012)

Back to basics: likelihood ratios for olive and grass pollen specific IgE in seasonal allergic rhinitis
por: Manzanares, Bárbara, et al.
Publicado: (2023)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option
por: Blaiss, Michael, et al.
Publicado: (2023)

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis
por: Pfaar, O., et al.
Publicado: (2017)

Linear Epitope Binding Patterns of Grass Pollen-Specific Antibodies in Allergy and in Response to Allergen-Specific Immunotherapy
por: Thörnqvist, Linnea, et al.
Publicado: (2022)

Specific Immunotherapy in a Murine Model of Grass Pollen (Phl p5b)-Induced Airway Inflammation
por: Stiehm, Matthias, et al.
Publicado: (2021)

Evaluation of the frequency and severity of seasonal allergic rhinoconjunctivitis caused by grass pollen in children with hazelnut sensitization
por: Cavkaytar, O, et al.
Publicado: (2013)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy
por: Ciprandi, Giorgio
Publicado: (2015)

7 Comparison of Efficacy and Safety of a Dipigmented Polymerized Allergen Extract of Grass and Birch with Placebo in Patients With Type-1 Allergic Rhinoconjunctivitis
por: Sager, Angelika, et al.
Publicado: (2012)

Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy
por: Poole, Chris D, et al.
Publicado: (2014)

Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population
por: Okamoto, Yoshitaka, et al.
Publicado: (2018)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)

A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
por: Alesina, Roberta, et al.
Publicado: (2012)

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children
por: Hébert, Jacques, et al.
Publicado: (2014)

Chemical modification by peroxynitrite enhances TLR4 activation of the grass pollen allergen Phl p 5
por: Reinmuth-Selzle, Kathrin, et al.
Publicado: (2023)

Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
por: Batard, Thierry, et al.
Publicado: (2019)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0d5o12gd36fv8tjm0ius7famvs